BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 11866264)

  • 1. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
    Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
    Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy.
    Lévy M; Copie-Bergman C; Gameiro C; Chaumette MT; Delfau-Larue MH; Haioun C; Charachon A; Hemery F; Gaulard P; Leroy K; Delchier JC
    J Clin Oncol; 2005 Aug; 23(22):5061-6. PubMed ID: 16051953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
    Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node involvement rate in low-grade gastric mucosa-associated lymphoid tissue lymphoma--too high to be neglected.
    Chang DK; Chin YJ; Kim JS; Jung HC; Kim CW; Song IS; Kim CY
    Hepatogastroenterology; 1999; 46(28):2694-700. PubMed ID: 10522067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
    Ono S; Kato M; Ono Y; Itoh T; Kubota K; Nakagawa M; Shimizu Y; Asaka M
    Gastrointest Endosc; 2008 Oct; 68(4):624-31. PubMed ID: 18534580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
    tho Pesch S; Müller W; Borchard F; Peters U
    Z Gastroenterol; 1994 Dec; 32(12):684-7. PubMed ID: 7871859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to eradicate Helicobacter pylori using amoxicillin and omeprazole in the remnant stomach.
    Rino Y; Imada T; Kabara T; Takahashi M; Shiozawa M; Ohshima T; Hasuo K; Inaba M; Yoneyama K; Yoshikawa T; Yukawa H; Kawamoto M; Tokunaga M; Takanashi Y
    Hepatogastroenterology; 2003; 50(54):2267-9. PubMed ID: 14696514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
    Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
    J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
    Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
    Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
    Uemura N; Mukai T; Okamoto S; Yamaguchi S; Mashiba H; Taniyama K; Sasaki N; Haruma K; Sumii K; Kajiyama G
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):639-42. PubMed ID: 9264278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.